Stagezero Life Sciences Ltd70 East Beaver Creek Road
Richmond Hill ON L4B 3B2 CAN
Sectors & Indices
StageZero Life Sciences Ltd is a Canadian company, focused on developing and commercializing proprietary molecular diagnostic tests for early detection of diseases and personalized health management, with a primary focus on cancer-related indications. It develops a proprietary platform technology, the Sentinel Principle, to identify novel biomarkers from whole blood. Its lead product, ColonSentry is a blood test to determine the patient's current risk of having colorectal cancer.
|James R. Howard-Tripp||CEO/Chairman of the Board/Director|